BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 11, 2009
View Archived Issues
Capsaicin does not impair neurologic function in postherpetic neuralgia patients
Read More
Meta-analysis data suggest possible effectiveness of levetiracetam in status epilepticus
Read More
Abbott describes novel cannabinoid CB2 receptor ligands as analgesics
Read More
Analyses point to efficacy of telmisartan/amlodipine combination in hypertension
Read More
Better blood pressure profile seen with naproxcinod than with naproxen in osteoarthritis patients
Read More
Analgesic efficacy seen with tanezumab in chronic low back pain patients
Read More
Intraocular polymer implant may improve visual acuity in AMD; preliminary phase II data presented
Read More
Vertex presents new voltage-gated sodium channel inhibitors with analgesic activity
Read More
Vernalis and Servier sign new three-year joint oncology collaboration
Read More
HGS and Novozymes amend license agreement for albumin fusion technology
Read More
Sirius and Vanderbilt University sign collaborative agreement for VALID study
Read More
Axelar reports preliminary results from phase I/II clinical trial of AXL-1717
Read More
Burzynski Research reports positive results from phase II trial of ANP therapy in OPG
Read More
Nycomed submits MAA to EMEA for PDE4 enzyme inhibitor Daxas in COPD
Read More
Pharmacopeia patent discloses Janus kinase 3 inhibitors as immmunosupressants
Read More
Novel histamine H1 receptor antagonists described by GSK as antiinflammatory agents
Read More
Gilead Sciences offers Q1 pipeline update
Read More
Actelion receives DSMB recommendation to continue with BUILD-3 study in IPF
Read More
AdventRx reports results from ANX-514 bioequivalence study
Read More
The FDA approves Cetraxal for external otitis
Read More
FDA accepts Acorda's NDA for fampridine for improving walking ability in people with MS
Read More
Isotechnika enters into strategic collaboration and financing agreement with Paladin
Read More
Maxygen and Cangene sign licensing agreement for MAXY-G34 in ARS
Read More
Exelixis and Boehringer to develop S1P1 agonists for autoimmune diseases
Read More
